Perrigo gets go-ahead for new infant products
This article was originally published in The Tan Sheet
Executive Summary
FDA approves Perrigo's first new infant formula products since the Allegan, Mich., firm acquired PBM Holdings in March. Perrigo's partner, Quebec-based Kerry Proteins and Nutritionals, will manufacture the products, the private labeler said Aug. 23. The approved products include concentrate and ready-to-use milk-based infant formula with arachidonic and docosahexaenoic acids. The ready-to-use product also comes in an organic version. "This is the first launch of new products since acquiring our infant nutrition business and we look forward to further new product introductions," said CEO Joseph Papa. Collins Stewart analysts said the approvals allow Perrigo to produce store brands to compete with Abbott's Similac Advance and Mead Johnson's Enfamil Premium (1"The Tan Sheet" March 29, 2010)
You may also be interested in...
Perrigo Grows Into Adjacent Infant Formula Category With PBM Acquisition
Perrigo takes the next step toward becoming a one-stop shop for private-label consumer health products with its $808 million acquisition of infant formula and baby food firm PBM Holdings Inc
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.